Home > Financial Ratios > VENUS REMEDIES

VENUS REMEDIES
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Core EBITDA Growth(%) 0.14-4.0759.1419.44-7.75

What is the latest Core EBITDA Growth ratio of VENUS REMEDIES ?

The latest Core EBITDA Growth ratio of VENUS REMEDIES is 0.14 based on Mar2023 Consolidated results.
Year Core EBITDA Growth
Mar20230.14
Mar2022-4.07
Mar202159.14
Mar202019.44
Mar2019-7.75

How is Core EBITDA Growth of VENUS REMEDIES Trending?

Years Core EBITDA Growth % Change
Mar2023 0.14
Positive
Mar2022 -4.07
Negative
Mar2021 59.14
204.22
Mar2020 19.44
Positive
Mar2019 -7.75 -

Other Financial Ratios of VENUS REMEDIES


Compare Core EBITDA Growth ratio of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹396.1 Cr -4.6% -13.8% 49.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹366,103.0 Cr 0.7% -4.8% 57.3% Stock Analytics
CIPLA ₹114,230.0 Cr 1.9% -2.4% 42.6% Stock Analytics
DIVIS LABORATORIES ₹103,916.0 Cr 0.1% 3% 12.1% Stock Analytics
ZYDUS LIFESCIENCES ₹99,939.2 Cr 1.3% 0.5% 87.4% Stock Analytics
DR REDDYS LABORATORIES ₹98,732.2 Cr -5.4% -4.1% 20% Stock Analytics


VENUS REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

-4.6%

-13.8%

49.4%

SENSEX

-1.5%

-2.6%

17.8%


You may also like the below Video Courses